{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:22:28Z","timestamp":1786119748923,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/sla.0b013e318216f374","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T16:13:42Z","timestamp":1301069622000},"page":"918-927","source":"Crossref","is-referenced-by-count":21,"title":["Genetic Variants in DNA Repair Predicts the Survival of Patients with Esophageal Cancer"],"prefix":"10.1097","volume":"253","author":[{"given":"Jang-Ming","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsuen","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Chi","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"23","key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer.","volume":"349","author":"Enzinger","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics, 2003.","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"R3-12-20210203","first-page":"403","article-title":"Esophageal cancer trends and risk factors.","volume":"21","author":"Blot","year":"1994","journal-title":"Semin Oncol"},{"issue":"1","key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance.","volume":"57","author":"Liang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009.","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"issue":"27","key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.athoracsur.2010.01.017","article-title":"Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.","volume":"89","author":"Hsu","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/bjs.6705","article-title":"Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.","volume":"96","author":"Morgan","year":"2009","journal-title":"Br J Surg"},{"issue":"4","key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jamcollsurg.2010.01.006","article-title":"Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing.","volume":"210","author":"Abate","year":"2010","journal-title":"J Am Coll Surg"},{"issue":"6","key":"R12-12-20210203","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1572-0241.2008.01889.x","article-title":"A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.","volume":"103","author":"Das","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"21","key":"R13-12-20210203","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1002\/cncr.24536","article-title":"Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly.","volume":"115","author":"Abrams","year":"2009","journal-title":"Cancer"},{"issue":"10","key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/cncr.23418","article-title":"Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection.","volume":"112","author":"Ishihara","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s11605-007-0385-7","article-title":"Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy.","volume":"12","author":"Kunisaki","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways.","volume":"14","author":"Martin","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"9","key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.dnarep.2007.02.010","article-title":"Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription.","volume":"6","author":"Laine","year":"2007","journal-title":"DNA Repair (Amst)"},{"issue":"10","key":"R18-12-20210203","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1101\/gad.10.10.1219","article-title":"The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.","volume":"10","author":"Wang","year":"1996","journal-title":"Genes Dev"},{"issue":"33","key":"R19-12-20210203","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/sj.onc.1202862","article-title":"Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.","volume":"18","author":"Robles","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"R20-12-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2004.10.032","article-title":"The DNA repair gene ERCC2XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.","volume":"223","author":"Yin","year":"2005","journal-title":"Cancer Lett"},{"issue":"3","key":"R21-12-20210203","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1055-9965.EPI-05-0749","article-title":"Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.","volume":"15","author":"Garcia-Closas","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3-4-260","key":"R22-12-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.canep.2009.08.002","article-title":"Polymorphisms in the nucleotide excision repair gene ERCC2XPD and risk of non-Hodgkin lymphoma.","volume":"33","author":"Worrillow","year":"2009","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"R23-12-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1215\/S1152851705000037","article-title":"ERCC1 and ERCC2 polymorphisms and adult glioma.","volume":"7","author":"Wrensch","year":"2005","journal-title":"Neuro Oncol"},{"issue":"3","key":"R24-12-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/mutage\/8.3.199","article-title":"Regional mapping of human DNA excision repair gene ERCC4 to chromosome 16p13.13-p13.2.","volume":"8","author":"Liu","year":"1993","journal-title":"Mutagenesis"},{"issue":"2","key":"R25-12-20210203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/cr040483f","article-title":"Molecular mechanisms of mammalian global genome nucleotide excision repair.","volume":"106","author":"Gillet","year":"2006","journal-title":"Chem Rev"},{"issue":"1","key":"R26-12-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijrobp.2007.10.068","article-title":"Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.","volume":"71","author":"Klopp","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"R27-12-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0921-8777(96)00036-5","article-title":"The importance of the ERCC1ERCC4XPF complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway.","volume":"364","author":"Murray","year":"1996","journal-title":"Mutat Res"},{"issue":"3","key":"R28-12-20210203","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.lungcan.2007.10.023","article-title":"Polymorphisms in excision repair cross-complementing group 4 (ERCC4) and susceptibility to primary lung cancer in a Chinese Han population.","volume":"60","author":"Shao","year":"2008","journal-title":"Lung Cancer"},{"issue":"4","key":"R31-12-20210203","first-page":"625","article-title":"A proposal for a new TNM classification of esophageal carcinoma.","volume":"15","year":"1985","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"R32-12-20210203","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.sla.0000186170.38348.7b","article-title":"Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.","volume":"242","author":"Schneider","year":"2005","journal-title":"Ann Surg"},{"issue":"1","key":"R33-12-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.pas.0000213312.36306.cc","article-title":"Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.","volume":"31","author":"Wu","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"R34-12-20210203","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.sla.0000157132.08833.98","article-title":"Association of angiotensin-converting enzyme insertiondeletion polymorphism with serum level and development of pulmonary complications following esophagectomy.","volume":"241","author":"Lee","year":"2005","journal-title":"Ann Surg"},{"issue":"14","key":"R35-12-20210203","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.","volume":"94","author":"Bosken","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"R36-12-20210203","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","article-title":"ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer.","volume":"127","author":"Simon","year":"2005","journal-title":"Chest"},{"issue":"11","key":"R37-12-20210203","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPDERCC2 alter mRNA expression.","volume":"17","author":"Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"R38-12-20210203","first-page":"627","article-title":"Gene expression profiling of breast cells induced by X-rays and heavy ions.","volume":"21","author":"Roy","year":"2008","journal-title":"Int J Mol Med"},{"issue":"19","key":"R39-12-20210203","doi-asserted-by":"crossref","first-page":"9420","DOI":"10.1158\/0008-5472.CAN-06-1418","article-title":"ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.","volume":"66","author":"Milne","year":"2006","journal-title":"Cancer Res"},{"issue":"13","key":"R40-12-20210203","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"R41-12-20210203","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/1078-0432.CCR-04-1101","article-title":"Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.","volume":"11","author":"Gu","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"R42-12-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6603290","article-title":"Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.","volume":"95","author":"Sakano","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"R43-12-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jtcvs.2008.05.024","article-title":"Factors predictive of prognosis after esophagectomy for squamous cell cancer.","volume":"137","author":"Li","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"R44-12-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/tpj.2009.19","article-title":"Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.","volume":"9","author":"Caronia","year":"2009","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"R45-12-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12032-009-9187-y","article-title":"Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.","volume":"27","author":"Gangawar","year":"2010","journal-title":"Med Oncol"},{"issue":"6","key":"R46-12-20210203","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-07-1364","article-title":"Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabinecisplatin-treated advanced non-small cell lung cancer patients.","volume":"14","author":"Tibaldi","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"5-6","key":"R47-12-20210203","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000113534","article-title":"Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatinfluoropyrimidine.","volume":"72","author":"Monzo","year":"2007","journal-title":"Oncology"},{"issue":"12","key":"R48-12-20210203","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2217\/14622416.8.12.1693","article-title":"Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.","volume":"8","author":"Le Morvan","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"5","key":"R49-12-20210203","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ijc.22411","article-title":"Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation.","volume":"120","author":"Vangsted","year":"2007","journal-title":"Int J Cancer"},{"issue":"26","key":"R50-12-20210203","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2006.05.8768","article-title":"DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.","volume":"24","author":"Quintela-Fandino","year":"2006","journal-title":"J Clin Oncol"},{"issue":"13","key":"R51-12-20210203","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2004-06-2161","article-title":"Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.","volume":"104","author":"Allan","year":"2004","journal-title":"Blood"},{"issue":"8","key":"R52-12-20210203","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/FPC.0b013e32832f3010","article-title":"Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.","volume":"19","author":"Bradbury","year":"2009","journal-title":"Pharmacogenet Genomics"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000658-201105000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:04Z","timestamp":1786042504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201105000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e318216f374","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}